The ASX200 pared intra-day gains, closing up 0.34% at 8,285 points, retreating from a fresh three week high of 8,297 points.
IT was the biggest winner, up 1.46%, followed by Telecommunication, up 1.25%, and Discretionary, up 0.72%
Utilities was the worst performer, down 0.87%, followed by Materials, down 0.54%.
4DMedical (ASX:4DX) closed up 14.7% after receiving US FDA clearance for its IQ-UIP product. An advanced AI-driven diagnostic tool that identifies Usual Interstitial Pneumonia, the product is a key radiological marker for diagnosing Interstitial Pulmonary Fibrosis.
4DMedical closed at 54.5 cents.
Santos (ASX:STO) finished up 1.4% following pleading guilty to charges related to a 2022 petroleum spill at its Varanus Island Marine Terminal which was linked to dolphin deaths.
The company was fined $10,000.
Santos closed at $6.96.
Capricorn Metals (ASX:CMM) closed up 2.2% on release of the gold miner’s quarterly update. The company’s Karlawinda Gold Project delivered another strong quarter of operations, producing 28,702 ounces of gold.
Capricorn Metals closed at $6.51.
Fortescue (ASX:FMG) closed down 4.4% in response to iron ore falling to around US$96 per tonne in Singapore.
Fortescue closed at $17.25.
Mesoblast (ASX:MSB) experienced profit-taking from some investors after the biotechnology company’s shares rocketed in 2024. The Mesoblast share price is up more than 900% since this time last year.
Mesoblast closed flat at $3.05.
Brainchip (ASX:BRN) closed down 5.3% on news of a capital raise through a put option agreement with LDA Capital.
Brainchip closed at 35.5 cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.